AVAH
AVAH
Aveanna Healthcare Holdings Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $662.48M ▲ | $133.3M ▼ | $178.75M ▲ | 26.98% ▲ | $0.88 ▲ | $80M ▲ |
| Q3-2025 | $621.94M ▲ | $143.95M ▲ | $14.06M ▼ | 2.26% ▼ | $0.07 ▼ | $55.67M ▼ |
| Q2-2025 | $589.55M ▲ | $130.77M ▼ | $27.02M ▲ | 4.58% ▲ | $0.13 ▲ | $87.11M ▲ |
| Q1-2025 | $559.22M ▲ | $131.76M ▲ | $5.19M ▼ | 0.93% ▼ | $0.03 ▼ | $51.78M ▼ |
| Q4-2024 | $519.87M | $125.95M | $29.18M | 5.61% | $0.15 | $70.57M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $193.26M ▲ | $2.03B ▲ | $1.83B ▲ | $194.46M ▲ |
| Q3-2025 | $145.87M ▲ | $1.81B ▲ | $1.8B ▲ | $9.91M ▲ |
| Q2-2025 | $100.74M ▲ | $1.77B ▲ | $1.78B ▲ | $-11.26M ▲ |
| Q1-2025 | $71.49M ▼ | $1.66B ▼ | $1.76B ▼ | $-98.67M ▲ |
| Q4-2024 | $84.29M | $1.66B | $1.79B | $-122.09M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $178.75M ▲ | $49.72M ▲ | $-1.95M ▲ | $-377K ▼ | $47.39M ▲ | $55.22M ▲ |
| Q3-2025 | $14.06M ▼ | $33.2M ▼ | $-2.02M ▲ | $13.95M ▲ | $45.13M ▲ | $31.18M ▼ |
| Q2-2025 | $27.02M ▲ | $51.57M ▲ | $-15.98M ▼ | $-6.34M ▼ | $29.24M ▲ | $50.44M ▲ |
| Q1-2025 | $5.19M ▼ | $-8.63M ▼ | $-2.35M ▼ | $-1.81M ▲ | $-12.79M ▼ | $-10.98M ▼ |
| Q4-2024 | $29.18M | $13.41M | $-1.53M | $-6.05M | $5.83M | $11.88M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Home Health And Hospice | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ | $70.00M ▲ |
Medical Solutions | $40.00M ▲ | $40.00M ▲ | $50.00M ▲ | $50.00M ▲ |
Private Duty Services | $460.00M ▲ | $490.00M ▲ | $510.00M ▲ | $540.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Aveanna Healthcare Holdings Inc.'s financial evolution and strategic trajectory over the past five years.
Aveanna combines meaningful scale, strong current‑period profitability, and solid operating and free cash flow with a distinctive niche in high‑acuity pediatric and complex‑care home services. Its technology‑enabled platform, specialized clinical programs, and growing network of preferred payer relationships provide strategic advantages that many smaller or less specialized competitors may struggle to match.
The company’s financial structure is fragile: high debt, negative equity, and tight liquidity create heightened sensitivity to any downturn in cash flows or reimbursement. A balance sheet dominated by goodwill and intangibles underscores reliance on past acquisitions, which may be vulnerable to impairment if performance slips. Sector‑wide headwinds—labor shortages, wage pressure, and reimbursement risk—compound these issues, and limited visible reinvestment raises questions about long‑term growth and asset renewal.
The outlook hinges on Aveanna’s ability to sustain current profitability and cash generation while gradually strengthening its balance sheet and continuing to leverage its technology and specialization. If operational improvements and value‑based partnerships continue to gain traction, the business has the ingredients for stable or improving performance in a growing home‑care market. At the same time, elevated leverage and structural industry challenges mean the path forward is likely to be sensitive to execution quality and broader policy and labor trends, leaving both upside and downside scenarios very plausible.
About Aveanna Healthcare Holdings Inc.
https://www.aveanna.comAveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $662.48M ▲ | $133.3M ▼ | $178.75M ▲ | 26.98% ▲ | $0.88 ▲ | $80M ▲ |
| Q3-2025 | $621.94M ▲ | $143.95M ▲ | $14.06M ▼ | 2.26% ▼ | $0.07 ▼ | $55.67M ▼ |
| Q2-2025 | $589.55M ▲ | $130.77M ▼ | $27.02M ▲ | 4.58% ▲ | $0.13 ▲ | $87.11M ▲ |
| Q1-2025 | $559.22M ▲ | $131.76M ▲ | $5.19M ▼ | 0.93% ▼ | $0.03 ▼ | $51.78M ▼ |
| Q4-2024 | $519.87M | $125.95M | $29.18M | 5.61% | $0.15 | $70.57M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $193.26M ▲ | $2.03B ▲ | $1.83B ▲ | $194.46M ▲ |
| Q3-2025 | $145.87M ▲ | $1.81B ▲ | $1.8B ▲ | $9.91M ▲ |
| Q2-2025 | $100.74M ▲ | $1.77B ▲ | $1.78B ▲ | $-11.26M ▲ |
| Q1-2025 | $71.49M ▼ | $1.66B ▼ | $1.76B ▼ | $-98.67M ▲ |
| Q4-2024 | $84.29M | $1.66B | $1.79B | $-122.09M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $178.75M ▲ | $49.72M ▲ | $-1.95M ▲ | $-377K ▼ | $47.39M ▲ | $55.22M ▲ |
| Q3-2025 | $14.06M ▼ | $33.2M ▼ | $-2.02M ▲ | $13.95M ▲ | $45.13M ▲ | $31.18M ▼ |
| Q2-2025 | $27.02M ▲ | $51.57M ▲ | $-15.98M ▼ | $-6.34M ▼ | $29.24M ▲ | $50.44M ▲ |
| Q1-2025 | $5.19M ▼ | $-8.63M ▼ | $-2.35M ▼ | $-1.81M ▲ | $-12.79M ▼ | $-10.98M ▼ |
| Q4-2024 | $29.18M | $13.41M | $-1.53M | $-6.05M | $5.83M | $11.88M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Home Health And Hospice | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ | $70.00M ▲ |
Medical Solutions | $40.00M ▲ | $40.00M ▲ | $50.00M ▲ | $50.00M ▲ |
Private Duty Services | $460.00M ▲ | $490.00M ▲ | $510.00M ▲ | $540.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Aveanna Healthcare Holdings Inc.'s financial evolution and strategic trajectory over the past five years.
Aveanna combines meaningful scale, strong current‑period profitability, and solid operating and free cash flow with a distinctive niche in high‑acuity pediatric and complex‑care home services. Its technology‑enabled platform, specialized clinical programs, and growing network of preferred payer relationships provide strategic advantages that many smaller or less specialized competitors may struggle to match.
The company’s financial structure is fragile: high debt, negative equity, and tight liquidity create heightened sensitivity to any downturn in cash flows or reimbursement. A balance sheet dominated by goodwill and intangibles underscores reliance on past acquisitions, which may be vulnerable to impairment if performance slips. Sector‑wide headwinds—labor shortages, wage pressure, and reimbursement risk—compound these issues, and limited visible reinvestment raises questions about long‑term growth and asset renewal.
The outlook hinges on Aveanna’s ability to sustain current profitability and cash generation while gradually strengthening its balance sheet and continuing to leverage its technology and specialization. If operational improvements and value‑based partnerships continue to gain traction, the business has the ingredients for stable or improving performance in a growing home‑care market. At the same time, elevated leverage and structural industry challenges mean the path forward is likely to be sensitive to execution quality and broader policy and labor trends, leaving both upside and downside scenarios very plausible.

CEO
Jeffrey S. Shaner
Compensation Summary
(Year 2024)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 108
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Barclays
Overweight
RBC Capital
Sector Perform
BMO Capital
Outperform
Truist Securities
Hold
UBS
Neutral
Jefferies
Buy
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
BAIN CAPITAL INVESTORS LLC
Shares:81.6M
Value:$545.91M
J.H. WHITNEY EQUITY PARTNERS VII, LLC
Shares:45.84M
Value:$306.67M
NUT TREE CAPITAL MANAGEMENT, LP
Shares:12.37M
Value:$82.77M
Summary
Showing Top 3 of 217

